348 results on '"McClellan, Mark B"'
Search Results
2. Bolstering FDA Pathways for Reducing Death and Disease from Tobacco
3. Comparing Associations of State Reopening Strategies with COVID-19 Burden
4. Current Policy and Practice for Value-Based Pricing
5. Using Digital Health Technology to Better Generate Evidence and Deliver Evidence-Based Care
6. Payment and Care for Hematopoietic Cell Transplantation Patients: Toward a Specialized Medical Home for Complex Care Patients
7. Improving Cardiovascular Drug and Device Development and Evidence Through Patient-Centered Research and Clinical Trials: A Call to Action From the Value in Healthcare Initiative’s Partnering With Regulators Learning Collaborative
8. Streamlining and Reimagining Prior Authorization Under Value-Based Contracts: A Call to Action From the Value in Healthcare Initiative’s Prior Authorization Learning Collaborative
9. Frontiers of Upstream Stroke Prevention and Reduced Stroke Inequity Through Predicting, Preventing, and Managing Hypertension and Atrial Fibrillation: A Call to Action From the Value in Healthcare Initiative’s Predict & Prevent Learning Collaborative
10. The Effects of Hospital Ownership on Medical Productivity
11. Moving Beyond the Walls of the Clinic: Opportunities and Challenges to the Future of Telehealth in Heart Failure
12. Is Hospital Competition Socially Wasteful?
13. Advancing Value-Based Models for Heart Failure: A Call to Action From the Value in Healthcare Initiative’s Value-Based Models Learning Collaborative
14. Advancing Value-Based Cardiovascular Care: The American Heart Association Value in Healthcare Initiative
15. The Effects of Malpractice Pressure and Liability Reforms on Physicians' Perceptions of Medical Care
16. Reforms Needed to Modernize the US Food and Drug Administration’s Oversight of Dietary Supplements, Cosmetics, and Diagnostic Tests
17. Correction to: Comparing Associations of State Reopening Strategies with COVID-19 Burden
18. Why a Proactive Perioperative Medicine Policy Is Crucial for a Sustainable Population Health Strategy
19. National Coronavirus Response: A ROAD MAP TO REOPENING
20. Addressing Antimicrobial Resistance and Stewardship: The Priority Antimicrobial Value and Entry (PAVE) Award
21. The 21st Century Cures Act
22. Remarks of the Commissioner of Food and Drugs
23. Understanding Use of Real‐World Data and Real‐World Evidence to Support Regulatory Decisions on Medical Product Effectiveness
24. Managed Care, Health Care Quality, and Regulation
25. Hospital‐level compliance with the commission on cancer’s quality of care measures and the association with patient survival
26. Health Expenditure Persistence and the Feasibility of Medical Savings Accounts
27. Vital Directions For Health And Health Care: Priorities For 2021
28. The Past Decade of Paying for Value : From the Affordable Care Act to COVID-19
29. Advance directives and medical treatment at the end of life
30. Understanding Use of Real‐World Data and Real‐World Evidence to Support Regulatory Decisions on Medical Product Effectiveness.
31. How liability law affects medical productivity
32. Utilization and outcomes of the implantable cardioverter defibrillator, 1987 to 1995
33. Trends in hospital treatment of ventricular arrhythmias among Medicare beneficiaries, 1985 to 1995
34. Building the Path to Accountable Care
35. Paying For Value From Costly Medical Technologies: A Framework For Applying Value-Based Payment Reforms
36. North Carolina's Health Care Transformation to Value
37. Toward Evidence-Based Policy Making to Reduce Wasteful Health Care Spending
38. Individual Expenditures and Medical Saving Accounts
39. .Satisfaction Guaranteed - "Payment by Results" for Biologic Agents
40. Medicare Part D: The First Months of the Prescription-Drug Benefit - A CMS Update
41. Medicare Drug Benefit: A Prescription for a Modern Medicare Program
42. Implantable Cardioverter-Defibrillators
43. Angiotensin-Converting Enzyme Inhibitors and Angiotensin-Receptor Blockers in Chronic Heart Failure
44. Medicare Coverage of ICDs
45. Use of Outcomes Research in Assuring Patient Safety and Quality Care, Second Plenary Session, ISPOR 8th Annual International Meeting, Arlington, VA, USA
46. Trends in Inpatient Treatment Intensity among Medicare Beneficiaries at the End of Life
47. FDA: protecting and advancing America's health.
48. Cost-Effectiveness of Alternative Management Strategies for Patients with Solitary Pulmonary Nodules
49. New Treatment for Hepatitis C
50. Two Drugs for Opioid Dependence
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.